Astellas And Pfizer's Xtandi(TM) (Enzalutamide) Shows Long-Term Overall Survival In Metastatic Hormone-Sensitive Prostate Cancer

Published: 2025-05-22 17:59:15 ET PFE

Published on 05/22/2025 at 17:59